1. Home
  2. BBGI vs RNAZ Comparison

BBGI vs RNAZ Comparison

Compare BBGI & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

N/A

Current Price

$3.70

Market Cap

10.5M

ML Signal

N/A

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$9.31

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBGI
RNAZ
Founded
1961
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
8.5M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
BBGI
RNAZ
Price
$3.70
$9.31
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$280.00
AVG Volume (30 Days)
8.8K
9.8K
Earning Date
05-06-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.50
EPS
N/A
N/A
Revenue
$232,179,463.00
N/A
Revenue This Year
$5.02
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
69.89
N/A
52 Week Low
$3.26
$0.22
52 Week High
$26.37
$20.99

Technical Indicators

Market Signals
Indicator
BBGI
RNAZ
Relative Strength Index (RSI) 40.64 45.18
Support Level N/A $8.47
Resistance Level $4.67 $9.70
Average True Range (ATR) 0.25 0.68
MACD 0.00 -0.07
Stochastic Oscillator 45.07 20.11

Price Performance

Historical Comparison
BBGI
RNAZ

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: